Byetta® warning increased by the U.S. Food & Drug Administration (FDA) due to deaths & cases of acute pancreatitis.
Free Byetta FDA Warning Case Evaluation: If you or a loved one has used Byetta and have been hospitalized with pancreatitis, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.
What’s the problem?
The FDA recently issued a warning about the potential link between acute pancreatitis and patients taking Byetta (exenatide). On August 18, 2008, the FDA reported on its website that of the 6 cases reported, all patients were hospitalized, and two of the patients died. Further, the use of Byetta was stopped in all cases.
Despite these reports of life-threatening Byetta side effects, the FDA has yet to issue an official Byetta recall that would take the medication off the market. Instead, the FDA has issued two national Byetta alerts:
- October 2007 – The FDA warned healthcare professionals that taking Byetta could cause patients to develop serious cases of pancreatitis (including acute, hemorrhagic and necrotizing pancreatitis).
- August 2008 – The FDA issued another Byetta warning, highlighting the fact that the agency received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta.
Following the second Byetta warning, the FDA started working with the maker of Byetta, Amylin Pharmaceuticals, Inc., to add stronger and more prominent warnings in the product label about the risk of acute hemorrhagic or necrotizing pancreatitis.
In January 2010, the FDA released a warning advising that Byetta has been linked to 30 confirmed cases of acute inflamed pancreatitis. The drug companies, Amylin and Eli Lilly, who co-developed this product will need to add this warning to its Byetta warning labels.
Do I have a Byetta Lawsuit?
The Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in Byetta lawsuits. We are handling individual litigation nationwide and currently accepting new cases in all 50 states.